LA JOLLA PHARMACEUTICAL CO's ticker is LJPC and the CUSIP is 503459604. A total of 35 filers reported holding LA JOLLA PHARMACEUTICAL CO in Q4 2014. The put-call ratio across all filers is - and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $24,292,000 | +46.7% | 813,800 | -13.9% | 0.01% | +33.3% |
| Q4 2016 | $16,561,000 | -27.9% | 944,700 | -2.2% | 0.01% | -25.0% |
| Q3 2016 | $22,972,000 | +48.7% | 965,600 | 0.0% | 0.01% | +50.0% |
| Q2 2016 | $15,450,000 | -23.5% | 965,600 | 0.0% | 0.01% | -27.3% |
| Q1 2016 | $20,191,000 | -22.6% | 965,600 | 0.0% | 0.01% | -15.4% |
| Q4 2015 | $26,071,000 | +2.9% | 965,600 | +5.9% | 0.01% | 0.0% |
| Q3 2015 | $25,342,000 | +5.0% | 911,900 | -7.4% | 0.01% | +18.2% |
| Q2 2015 | $24,133,000 | +43.3% | 984,600 | +7.0% | 0.01% | +37.5% |
| Q1 2015 | $16,843,000 | -0.8% | 920,400 | 0.0% | 0.01% | 0.0% |
| Q4 2014 | $16,981,000 | +92.0% | 920,400 | 0.0% | 0.01% | +100.0% |
| Q3 2014 | $8,845,000 | +4.7% | 920,400 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $8,449,000 | – | 920,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG KEVIN C | 240,000 | $1,027,000 | 95.09% |
| TANG CAPITAL MANAGEMENT LLC | 10,049,224 | $43,011,000 | 8.56% |
| RTW INVESTMENTS, LP | 2,327,903 | $9,963,000 | 0.15% |
| Boxer Capital, LLC | 890,700 | $3,812,000 | 0.13% |
| Tibra Equities Europe Ltd | 72,600 | $311,000 | 0.10% |
| WealthTrust Axiom LLC | 25,400 | $108,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 52,749 | $226,000 | 0.02% |
| FIRST MIDWEST BANK TRUST DIVISION | 34,231 | $147,000 | 0.02% |
| HOLLENCREST CAPITAL MANAGEMENT | 42,355 | $181,000 | 0.02% |
| Summit Global Investments | 48,500 | $208,000 | 0.01% |